How do you think the new GigE standards will influence the machine vision industry?
Respond or ask your question now!
Other applications of HDC's newly issued patent include analysis of microscopic images of samples, such as tissue and blood, from a patient. Examples of such applications for blood samples include circulating tumor and endothelial cell analyses, which are gaining recognition as predictive of outcome in certain cancers like breast cancer and have significant value in determining the direction, and monitoring efficacy of treatment.
Examples of tissue samples include microscopic images for surgical specimens and biopsies for determining diagnosis and progression of cancer. The ability to automatically analyze every image using CAD software and produce a summary result, as provided by HDC's patented method, greatly increases the reliability of the analysis as well as the time required to complete it. HDC's additional claims covering in vivo analysis methods and their applications are pending before the U.S. Patent Office.
HDC's issued patents cover methods and systems for preprocessing of data to enhance knowledge discovery using SVM's, analysis of data using multiple SVM's and for multiple data sets, and providing SVM analysis services over the Internet.
HDC's pending U.S. and foreign patent applications cover numerous improvements to and applications of SVM's including computer-aided image analysis using SVM's, with particular application to diagnosis using medical images, methods of feature selection for enhanced SVM efficiency and biomarkers for colon cancer, prostate cancer and renal cancer discovered with these methods, and use of SVM's for analysis of spectral data, such as mass spectrometry data used for protein analysis.
This article was prepared by Health & Medicine Week editors from staff and other reports. Copyright 2006, Health & Medicine Week via NewsRx.com.
<<Health & Medicine Week -- 03/14/06>>